Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1644-1648

  Akahoshi, Mitsuteru ^a   Nakashima, Hitoshi ^a   Tanaka, Yosuke ^a   Kohsaka, Tsutomu ^b   Nagano, Shuji ^a   Ohgami, Eiichi ^a   Arinobu, Yojiro ^a   Yamaoka, Kunihiro ^a   Niiro, Hiroaki ^a   Shinozaki, Michiya ^a   Hirakata, Hideki ^a   Horiuchi, Takahiko ^a   Otsuka, Takeshi ^a   Niho, Yoshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Otsuka Tokyo Assay Laboratories   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ADULT; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 0033509042     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L     Document Type: Article

References (35)

1. Klinman DM, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995;144:157-93.
2. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-390.
3. Kotzin BL. Systemic lupus erythematosus. Cell 1996;85:303-6.
4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
5. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W mice. J Exp Med 1994;179:305-10.
6. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1994;178:87-99.
7. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-6.
8. Nicholson LB, Greer JM, Sobel RA, Lees MB, Kuchroo VK. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 1995;3:397-405.
9. Ogawa N, Itoh M, Goto Y. Abnormal production of B cell growth factor in patients with systemic lupus erythematosus. Clin Exp Immunol 1992;89:26-31.
10. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus: a putative role in pathogenesis. J Immunol 1991;147: 117-23.
11. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot M, Durand-Gasselin I, et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993;4:421-30.
12. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic disease. J Clin Immunol 1993;13:58-67.
13. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996;97:1597-604.
14. Peng SL, Moslehi J, Craft J. Roles of interferon-γ and interleukin-4 in murine lupus. J Clin Invest 1997;99:1936-46.
15. Segal R, Bermas BL, Dayan M, Kalush F, Shearer GM, Mozes E. Kinetics of cytokine production in experimental systemic lupus crythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol 1997;158:3009-16.
16. Churg J, Bernstein J, Glassock RJ. Lupus nephritis. In: Churg J, Bernstein J, Glassock RJ, editors. Renal diseases: classification and atlas of glomerular diseases. New York: Igaku-Shoin; 1995. p. 151.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
19. Jung T, Schauer U, Hausser C, Neumann C, Reiger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993;159:197-207.
20. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998;34:207-15.
21. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-19.
22. Openshaw P, Murphy EE, Hosken NA, Mario V, Davis K, Murphy K, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;185:1357-67.
23. Haas C, Ryffel B, Le Hir M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J Immunol 1997;158:5484-91.
24. lpr mice. J Immunol 1998;161:494-503.
25. Jacob CO, van der Meide PH, McDevitt HO. In vivo treatment of (NZB×NZW)Fl lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 1987;166:798-803.
26. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G. Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995;25:6-12.
27. Snapper CM, McIntyre TM, Mandler R, Pecanha LMT, Finkelman FD, Lees A, et al. Induction of IgG3 secretion by interferon γ: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 1992;175:1367-71.
28. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991;147:515-9.
29. Santiago M-L, Fossati L, Jacquet C, Muler W, Izui S, Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997;185:65-70.
30. Roberts JL, Wyatt RJ, Schwartz MM, Lewis EJ. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis. Clin Immunol Immunopathol 1986;29:223-41.
31. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest 1998;101:364-71.
32. Gerald BA, Fred GS, Conrad LP, Jay IM, Dorothy E. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) 1978;57:371-410.
33. Noel LH, Aucouturier P, Monteiro RC, Preud'homme J-L, Lesavre P. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol 1988;46:186-94.
34. Tanaka Y, Nakashima H, Hisano C, Kohsaka T, Nemoto Y, Niiro H, et al. Association of the interferon-γ receptor variant (Vall4Met) with systemic lupus erythematosus. Immunogenetics 1999;49:266-71.
35. Duit AJ, Bootsma H, Derksen RHWM, Spronk PE, Kater L, Kallenberg CGM, et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 1995;38:1832-6.